Brigit Biofarmaka Teknologi Tbk. vs Bakrie Sumatera Plantations Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Bakrie Sumatera Plantations Tbk. trades at Rp206 (market cap 495.03B, 8.12M 24h volume). The key difference: Bakrie Sumatera Plantations Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bakrie Sumatera Plantations Tbk. is more actively traded (8.12M versus 324K). Which is the better fit depends on your goals.
| OBAT | UNSP | |
|---|---|---|
Market Cap | 166.01B | 495.03B |
Volume | 324K | 8.12M |
Lot | 3.24K | 81.22K |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Bakrie Sumatra Plantation Tbk (the Company) was established in the Republic of Indonesia in 1911 as a joint venture between the United States and Netherland Companies under the name of NV Hollandsch Amerikaanse Plantage Maatschappij. The Company status is Domestic Investment and has 8822 employees.
Read more on UNSP →